Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis.
Moreland LW, McCabe DP, Caldwell JR, Sack M, Weisman M, Henry G, Seely JE, Martin SW, Yee CL, Bendele AM, Frazier JL, Kohno T, Cosenza ME, Lyons SA, Dayer JM, Cohen AM, Edwards CK 3rd.
Moreland LW, et al. Among authors: lyons sa.
J Rheumatol. 2000 Mar;27(3):601-9.
J Rheumatol. 2000.
PMID: 10743796
Clinical Trial.